Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18096 | 504 | 44.3 | 92% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEUROTRAUMA VARIAT REGENERAT | Address | 14 | 59% | 3% | 16 |
2 | TIANTAN HOSP | Address | 7 | 27% | 5% | 23 |
3 | OTORHINOLARYNGOL MAXILLO IAL ONCOL | Address | 6 | 80% | 1% | 4 |
4 | MIR 128 | Author keyword | 5 | 42% | 2% | 10 |
5 | PEOPLES HOSP KUNSHAN 1 | Address | 5 | 27% | 3% | 15 |
6 | HOSP YANCHENG 1 | Address | 4 | 56% | 1% | 5 |
7 | AFFILIATED YANCHENG HOSP 4 | Address | 4 | 46% | 1% | 6 |
8 | TIANJIN NEUROL | Address | 3 | 14% | 4% | 21 |
9 | TIANJIN BASIC MED SCI | Address | 3 | 21% | 2% | 12 |
10 | MICRORNA 128 | Author keyword | 3 | 60% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MIR 128 | 5 | 42% | 2% | 10 | Search MIR+128 | Search MIR+128 |
2 | MICRORNA 128 | 3 | 60% | 1% | 3 | Search MICRORNA+128 | Search MICRORNA+128 |
3 | MIRNA 128 | 3 | 60% | 1% | 3 | Search MIRNA+128 | Search MIRNA+128 |
4 | MICRORNA 326 | 2 | 67% | 0% | 2 | Search MICRORNA+326 | Search MICRORNA+326 |
5 | MICRORNA 10B | 2 | 40% | 1% | 4 | Search MICRORNA+10B | Search MICRORNA+10B |
6 | MIR 222 | 2 | 19% | 2% | 9 | Search MIR+222 | Search MIR+222 |
7 | ECOP | 2 | 43% | 1% | 3 | Search ECOP | Search ECOP |
8 | MIR 221 | 2 | 13% | 2% | 11 | Search MIR+221 | Search MIR+221 |
9 | MIR 124 | 2 | 13% | 2% | 11 | Search MIR+124 | Search MIR+124 |
10 | CDA 2 | 1 | 100% | 0% | 2 | Search CDA+2 | Search CDA+2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HSA MIR 181B | 9 | 64% | 2% | 9 |
2 | CHEMOTHERAPEUTIC DRUG TEMOZOLOMIDE | 6 | 71% | 1% | 5 |
3 | MICRORNA 21 | 2 | 14% | 3% | 16 |
4 | MULTIFORME CELLS | 2 | 32% | 1% | 6 |
5 | EGFR PATHWAY | 1 | 38% | 1% | 3 |
6 | HUMAN URINE EXTRACT | 1 | 100% | 0% | 2 |
7 | MICRORNA 494 | 1 | 50% | 0% | 2 |
8 | U87MG CELLS | 1 | 19% | 1% | 5 |
9 | MIR 128 | 1 | 40% | 0% | 2 |
10 | CLONOGENIC DEATH | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
A Systematic Review of MicroRNA in Glioblastoma Multiforme: Micro-modulators in the Mesenchymal Mode of Migration and Invasion | 2013 | 25 | 109 | 65% |
Emerging Roles of microRNA in Modulating Cell-Death Processes in Malignant Glioma | 2014 | 13 | 109 | 28% |
Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy | 2012 | 30 | 107 | 49% |
MicroRNAs in cancer: Glioblastoma and glioblastoma cancer stem cells | 2014 | 6 | 99 | 41% |
MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications | 2011 | 22 | 48 | 58% |
MicroRNA Expression Signatures Determine Prognosis and Survival in Glioblastoma Multiforme-a Systematic Overview | 2014 | 2 | 166 | 55% |
Role of MicroRNAs in Malignant Glioma | 2015 | 0 | 67 | 67% |
The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma sternness | 2014 | 6 | 119 | 27% |
A major role for microRNAs in glioblastoma cancer stem-like cells | 2015 | 0 | 113 | 64% |
MicroRNAs involved in chemo- and radioresistance of high-grade gliomas | 2013 | 7 | 67 | 40% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROTRAUMA VARIAT REGENERAT | 14 | 59% | 3.2% | 16 |
2 | TIANTAN HOSP | 7 | 27% | 4.6% | 23 |
3 | OTORHINOLARYNGOL MAXILLO IAL ONCOL | 6 | 80% | 0.8% | 4 |
4 | PEOPLES HOSP KUNSHAN 1 | 5 | 27% | 3.0% | 15 |
5 | HOSP YANCHENG 1 | 4 | 56% | 1.0% | 5 |
6 | AFFILIATED YANCHENG HOSP 4 | 4 | 46% | 1.2% | 6 |
7 | TIANJIN NEUROL | 3 | 14% | 4.2% | 21 |
8 | TIANJIN BASIC MED SCI | 3 | 21% | 2.4% | 12 |
9 | RUMENT SCI ENGN THIN FILM MI | 2 | 67% | 0.4% | 2 |
10 | HEAD NECK CANC 1 | 2 | 50% | 0.6% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000264889 | MICRORNA//MIR 21//MICRORNAS |
2 | 0.0000246555 | MIR 34A//MICRORNA 34A//MIR 34 |
3 | 0.0000185649 | BRAIN TUMOR STEM CELL//GLIOMA STEM CELLS//BRAIN TUMOR STEM CELLS |
4 | 0.0000156668 | IDH1//IDH2//ISOCITRATE DEHYDROGENASE 1 |
5 | 0.0000144187 | JR GRP SFB488//INTERDISZIPLINA ZENTRUM NEUROWISSEN//MIR137 |
6 | 0.0000126759 | PDCD4//PROGRAMMED CELL DEATH 4//PROGRAMMED CELL DEATH 4 PDCD4 |
7 | 0.0000105098 | MIR 210//MICRORNA 210//C19MC |
8 | 0.0000093803 | MIR 122//MICRORNA 122//MIR 224 |
9 | 0.0000092371 | MAZUMDAR SHAW TRANSLAT//2 DIMENSIONAL LIQUID CHROMATOGRAPHY//BIOLOGICAL VARIATION ANALYSIS |
10 | 0.0000085890 | GW182//DROSHA//ARGONAUTE |